Clinical Trial Update: Exercise as an Immune Adjuvant for Allogeneic Cell Therapies [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is exploring whether exercise can boost immune response as an adjuvant to allogeneic cell therapies, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Snippet

Sponsor: University of Arizona | Conditions: Leukemia, Hematopoetic Stem Cell Transplantation | EARLY_Phase 1 | Status: RECRUITING